A patient with heparin-induced thrombocytopenia (HIT) may develop skin lesions at the sites of subcutaneous heparin injection.
Clinical features:
(1) history of subcutaneous injection of heparin
(2) presence of anti-heparin antibodies
(3) development of lesions at the injection sites that may be painful and/or pruritic:
(3a) indurated, erythematous nodules or plaques
(3b) necrosis of overlying skin with formation of an eschar
Associated findings may include:
(1) thrombocytopenia, especially if there is continued use of heparin
(2) arterial and/or venous thrombosis
Skin biopsy may show:
(1) thrombosis of small dermal blood vessels
(2) edema
(3) dermal lymphocytic infiltrate
(4) subcutaneous fat necrosis
Differential diagnosis:
(1) infection at the injection site
(2) panniculitis
To read more or access our algorithms and calculators, please log in or register.
Specialty: Hematology Oncology, Clinical Laboratory, Pharmacology, clinical, Critical Care, Immunology/Rheumatology